BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19339740)

  • 1. Characterization of effector T cells in dry eye disease.
    El Annan J; Chauhan SK; Ecoiffier T; Zhang Q; Saban DR; Dana R
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3802-7. PubMed ID: 19339740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis.
    Chen Y; Chauhan SK; Lee HS; Stevenson W; Schaumburg CS; Sadrai Z; Saban DR; Kodati S; Stern ME; Dana R
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2457-64. PubMed ID: 23482465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
    Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities.
    Ji YW; Seo Y; Choi W; Yeo A; Noh H; Kim EK; Lee HK
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6829-38. PubMed ID: 25257053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease.
    Coursey TG; Gandhi NB; Volpe EA; Pflugfelder SC; de Paiva CS
    PLoS One; 2013; 8(11):e78508. PubMed ID: 24223818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease.
    Guzmán M; Keitelman I; Sabbione F; Trevani AS; Giordano MN; Galletti JG
    Clin Exp Immunol; 2016 May; 184(2):248-56. PubMed ID: 26690299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation.
    El Annan J; Goyal S; Zhang Q; Freeman GJ; Sharpe AH; Dana R
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3418-23. PubMed ID: 20019373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 Receptor E and C-C Motif Chemokine Receptor 10 Identify Heterogeneous T Helper 17 Subsets in a Mouse Dry Eye Disease Model.
    Wang J; Gong J; Yang Q; Wang L; Jian Y; Wang P
    Am J Pathol; 2022 Feb; 192(2):332-343. PubMed ID: 35144761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to Traffic-Related Particulate Matter 2.5 Triggers Th2-Dominant Ocular Immune Response in a Murine Model.
    Lee HS; Han S; Seo JW; Jeon KJ
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32344779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
    Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease.
    Gao Y; Min K; Zhang Y; Su J; Greenwood M; Gronert K
    J Immunol; 2015 Oct; 195(7):3086-99. PubMed ID: 26324767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
    Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
    J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
    Na KS; Mok JW; Kim JY; Rho CR; Joo CK
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression.
    Chauhan SK; El Annan J; Ecoiffier T; Goyal S; Zhang Q; Saban DR; Dana R
    J Immunol; 2009 Feb; 182(3):1247-52. PubMed ID: 19155469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary DHA amplifies LXA
    Gao Y; Su J; Zhang Y; Chan A; Sin JH; Wu D; Min K; Gronert K
    Mucosal Immunol; 2018 Nov; 11(6):1674-1683. PubMed ID: 30104626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection.
    Inomata T; Hua J; Nakao T; Shiang T; Chiang H; Amouzegar A; Dana R
    Cornea; 2018 Jan; 37(1):95-101. PubMed ID: 29023237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Dendritic Cells in Dry Eye Mouse Model.
    Maruoka S; Inaba M; Ogata N
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3269-3277. PubMed ID: 29971446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 ligand promotes priming of fully potent antitumor CD4(+) T cells in draining lymph nodes in the presence of apoptotic tumor cells.
    Fujita N; Kagamu H; Yoshizawa H; Itoh K; Kuriyama H; Matsumoto N; Ishiguro T; Tanaka J; Suzuki E; Hamada H; Gejyo F
    J Immunol; 2001 Nov; 167(10):5678-88. PubMed ID: 11698440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis.
    Murphy CC; Duncan L; Forrester JV; Dick AD
    Br J Ophthalmol; 2004 Mar; 88(3):412-6. PubMed ID: 14977779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation.
    Yu M; Lee SM; Lee H; Amouzegar A; Nakao T; Chen Y; Dana R
    Am J Pathol; 2020 Jan; 190(1):125-133. PubMed ID: 31669306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.